Retatrutide

TIMELESS RESEARCH LIBRARY

Retatrutide

Triple Receptor Agonist (GLP-1 • GIP • Glucagon Receptor)

View Product →
01 — OVERVIEW

Research Overview

Retatrutide is an investigational multi-receptor peptide studied for its simultaneous activity at the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. By engaging three distinct metabolic pathways, Retatrutide has become an important compound in preclinical and clinical research focused on energy regulation, nutrient utilization, and body composition.

Researchers continue to investigate its pharmacological profile, receptor interactions, and metabolic effects in controlled laboratory settings. As with all compounds offered by Timeless Peptides, Retatrutide is supplied exclusively for laboratory and scientific research purposes.

02 — RESEARCH

Research Highlights

• Investigated for multi-pathway metabolic signaling through GLP-1, GIP, and glucagon receptor activation.

• Studied for its effects on energy expenditure and nutrient metabolism in controlled research models.

• Ongoing research explores changes in body composition and metabolic regulation.

• Evaluated for receptor binding characteristics and downstream cellular signaling.

• Manufactured in FDA-registered facilities and independently third-party tested for identity and purity.

• Intended exclusively for laboratory research and not for human consumption.

03 — HANDLING

Storage Information

• Store refrigerated between 2°C and 8°C (36°F–46°F).

• Protect from direct light and excessive heat.

• Keep the vial sealed until ready for laboratory use.

• After reconstitution, maintain refrigeration and minimize repeated temperature fluctuations.

• For research use only. Keep out of reach of unauthorized personnel.

CERTIFICATES OF ANALYSIS

Available Documentation

Browse batch-specific testing documentation for Retatrutide.